1. Home
  2. LYRA vs CLRO Comparison

LYRA vs CLRO Comparison

Compare LYRA & CLRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LYRA
  • CLRO
  • Stock Information
  • Founded
  • LYRA 2005
  • CLRO 1983
  • Country
  • LYRA United States
  • CLRO United States
  • Employees
  • LYRA N/A
  • CLRO N/A
  • Industry
  • LYRA Medical/Dental Instruments
  • CLRO Radio And Television Broadcasting And Communications Equipment
  • Sector
  • LYRA Health Care
  • CLRO Technology
  • Exchange
  • LYRA Nasdaq
  • CLRO Nasdaq
  • Market Cap
  • LYRA 11.3M
  • CLRO 9.3M
  • IPO Year
  • LYRA 2020
  • CLRO N/A
  • Fundamental
  • Price
  • LYRA $7.51
  • CLRO N/A
  • Analyst Decision
  • LYRA Hold
  • CLRO
  • Analyst Count
  • LYRA 1
  • CLRO 0
  • Target Price
  • LYRA $16.00
  • CLRO N/A
  • AVG Volume (30 Days)
  • LYRA 39.0K
  • CLRO 51.8K
  • Earning Date
  • LYRA 11-11-2025
  • CLRO 11-14-2025
  • Dividend Yield
  • LYRA N/A
  • CLRO N/A
  • EPS Growth
  • LYRA N/A
  • CLRO N/A
  • EPS
  • LYRA N/A
  • CLRO N/A
  • Revenue
  • LYRA $770,000.00
  • CLRO $9,689,000.00
  • Revenue This Year
  • LYRA N/A
  • CLRO N/A
  • Revenue Next Year
  • LYRA $123.83
  • CLRO N/A
  • P/E Ratio
  • LYRA N/A
  • CLRO N/A
  • Revenue Growth
  • LYRA N/A
  • CLRO N/A
  • 52 Week Low
  • LYRA $3.81
  • CLRO $3.83
  • 52 Week High
  • LYRA $37.50
  • CLRO $21.00
  • Technical
  • Relative Strength Index (RSI)
  • LYRA 52.58
  • CLRO N/A
  • Support Level
  • LYRA $6.55
  • CLRO N/A
  • Resistance Level
  • LYRA $8.75
  • CLRO N/A
  • Average True Range (ATR)
  • LYRA 0.54
  • CLRO 0.00
  • MACD
  • LYRA 0.15
  • CLRO 0.00
  • Stochastic Oscillator
  • LYRA 35.03
  • CLRO 0.00

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

About CLRO ClearOne Inc. (DE)

ClearOne Inc is a communications solutions company, which is engaged in designing, developing, and selling conferencing, collaboration, streaming, and digital signage solutions for audio, video, and visual communication. It sells its commercial products to end-users predominantly through a network of independent distributors, who in turn sell its products to dealers, systems integrators, and other resellers. Its products include DSP mixers, amplifiers, Video walls, professional cameras, and professional microphones among others. Geographically the firm has its business presence across the United States and international markets.

Share on Social Networks: